Ingestible device with pharmaceutical product

1. A pharmaceutical product, comprising:

a capsule having an upper end and a lower end, wherein the upper and lower ends are brought together to form a housing that defines a cavity and wherein the cavity is filled with a drug, the capsule configured to disintegrate when in contact with a surrounding fluid; and

an ingestible device associated with the capsule to encode information in a current signature, wherein the ingestible device is placed within the housing, wherein the ingestible device comprises electronic components that are surrounded by a protective layer, the protective layer comprising a plurality of legs protruding outwardly from the electronic components, and wherein the protective layer is configured to begin to disintegrate after the capsule has disintegrated and has exposed the content of the capsule to the surrounding fluids.

2. The product of claim 1 , wherein the plurality of legs are configured to hold the ingestible device in place within the housing by applying friction to one or more inner walls of the housing.

3. The product of claim 2 , wherein either the upper end or the low end of the capsule comprises material within the cavity to define a plurality of slots that are configured to engage the plurality of legs of the ingestible device to lock the ingestible device into place mechanically.

4. The product of claim 3 , wherein the number of legs in the plurality of legs differs from the number of slots in the plurality of slots.

5. The product of claim 1 , wherein the protective layer is configured to prevent at least one of the capsule or the drug from interacting with the electronic components of the ingestible device.

6. The product of claim 1 , further comprising:

a flexible membrane that is secured to the ingestible device to produce an assembly wherein the flexible membrane positions the assembly within the capsule;

a first protective sheet secured to an upper surface of the assembly; and

a second protective sheet secured to a lower surface of the assembly, wherein the first protective sheet and the second protective sheet are secured to each other and surround the assembly.

7. The product of claim 6 , wherein the delayed exposure delays activation of the ingestible device.

8. A pharmaceutical product, comprising:

a housing that defines a cavity, wherein the cavity stores a pharmaceutical material, and wherein the housing comprises a material configured to dissolve based on contact with a fluid;

an ingestible device to encode information in a current signature, wherein the ingestible device is positioned within the housing; and

a protective material that encompasses the ingestible device, the protective layer comprising a plurality of legs protruding outwardly that are configured to hold the ingestible device in place within the housing by applying friction to one or more inner walls of the housing.

9. The product of claim 8 , wherein the ingestible device further comprises at least one of electronic components or dissolvable components protected by the protective material.

10. The product of claim 8 , wherein the ingestible device is attached to a flexible component, and wherein the flexible component is configured to releasably secure the ingestible device within the housing.

11. The product of claim 8 , wherein the pharmaceutical material comprises at least one of a drug, an excipient, or a compound.

12. The product of claim 8 , wherein the protective material encompasses the ingestible device by laminating or encasing the ingestible device, and wherein the protective material is configured to dissolve based on contact with the fluid.

13. The product of claim 12 , wherein the protective material is configured to dissolve relative to the material of the housing to delay exposure of the ingestible device to the fluid.

14. The product of claim 8 , wherein the protective material comprises two different materials.

15. A pharmaceutical product, comprising:

a soluble structure comprising a pharmaceutical material;

an electronic unit to encode information in a current signature, wherein the electronic unit is secured within the soluble structure; and

a protective material that surrounds the electronic unit, the protective layer comprising a plurality of legs protruding outwardly from the electronic unit that are configured to hold the electronic unit in place within the soluble structure by applying friction to one or more inner walls of the soluble structure, wherein the protective material is configured to dissolve based on contact with a fluid.

16. The product of claim 15 , wherein the soluble structure defines a cavity in which the electronic unit is secured in, and the soluble structure further comprises material within the cavity to define a plurality of slots that are configured to engage the plurality of legs of the protective material to lock the electronic unit into place mechanically.

17. The product of claim 15 , wherein the protective material is configured to dissolve relative to the soluble structure to delay exposure of the electronic unit to the fluid.

18. The product of claim 15 , wherein the protective material is configured to prevent the pharmaceutical material from interacting with a component of the electronic unit.

19. The product of claim 15 , wherein the protective material comprises a first sheet and a second sheet, and wherein the first sheet is secured to the second sheet to form a pocket that surrounds the electronic unit.

20. The product of claim 19 , wherein the electronic unit is attached to a flexible skirt comprising a plurality of holes, and wherein the first sheet is further secured to the second sheet through the plurality of holes to secure the electronic unit within the pocket.